跳至主要内容
临床试验/NCT06776601
NCT06776601招募中不适用

Digital Therapy in Self-management of Chronic Obstructive Pulmonary Disease Patients:A Prospective, Open-labled, Multicenter Randomized Controlled Clinical Study.

China-Japan Friendship Hospital1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年7月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
600
试验地点
1
主要终点
severe exacerbation

研究概览

简要总结

This project adopts a whole-process digital therapy intervention package composed of an inhalation technique assessment device, an electronic inhalant medication monitoring device and digital software to guide patients use the inhaler correctly personalizedly, record and manage the behavior data of chronic obstructive pulmonary disease (COPD) patients during the use of inhalant medication, and provide personalized reminders and feedback to patients according to the data. The purpose is to analyze whether this digital intervention scheme can reduce the number of acute exacerbations of COPD, improve the management effect of COPD, and reduce the burden of disease by improving the medication compliance of COPD patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with COPD
  • Aged 40 and above
  • Had one or more severe acute exacerbations in the past year, and be in stable condition for the last 4 weeks
  • Can operate a smartphone proficiently
  • Take inhalation medication suits for the inhalation monitoring device as treatment
  • Fully understand and be willing to sign the informed consent form

排除标准

  • Certain comorbidities (e.g. unstable coronary complications)
  • Undergone thoracic, abdominal or ophthalmic surgery in recent 3 months
  • Pregnant or lactating women
  • ABS allergy history

结局指标

主要结局

severe exacerbation

时间窗: 12 month

Proportion of patients with severe acute exacerbation of COPD pulmonary disease during the follow-up period.

次要结局

  • First Second Forced Expiratory Volume/ Forced Vital Capacity(12 month)
  • First Second Forced Expiratory Volume percentage of estimated(12 month)
  • peak expiratory flow(12 month)
  • COPD Assessment Test score(12 month)
  • modified Medical Research Council scale(12 month)
  • St. George's Respiratory Questionnairefor chronic obstructive pulmonary disease (SGRQ) score(12 month)
  • peak inspiratory flow rate(12 month)
  • mild and moderate exacerbation(12 month)

研究者

发起方
China-Japan Friendship Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongtao Niu

PhD

China-Japan Friendship Hospital

研究点 (1)

Loading locations...

相似试验